Pressure Ulcers Treatment Market

A prominent research firm, Cognizance Market Research added a cutting-edge industry report on the ” Pressure Ulcers Treatment Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2022 to 2030.

Pressure Ulcers Treatment Market Analysis:

According to cognizance market research the Pressure Ulcers Treatment Market is expected to register a CAGR of 6.4% from 2022 to 2030.

What is Pressure Ulcers Treatment Market?

Pressure ulcers, also known as bedsores or pressure sores, are skin and underlying tissue lesions caused by continuous pressure on the skin. They are most frequent in people who are bedridden, wheelchair-bound, or have restricted movement and are at risk of developing pressure ulcers due to constant pressure on certain body parts. Infections, sepsis, and even death can occur as a result of pressure ulcers.

Products and therapies used to prevent and treat pressure ulcers are included in the pressure ulcer treatment market. Dressings, topical agents, support surfaces, and medical devices are examples of these items and therapies. The market is being pushed by the rising prevalence of pressure ulcers, particularly among the elderly, as well as increased awareness of the necessity of avoiding and treating pressure ulcers.

The market for pressure ulcer therapy is quite competitive, with multiple manufacturers offering a diverse variety of goods and methods. Smith & Nephew plc, Mölnlycke Health Care AB, Acelity L.P. Inc., Coloplast A/S, and ConvaTec Group plc are among the market’s prominent participants. These firms are substantially spending R&D to provide novel products and therapies that can successfully prevent and treat pressure ulcers.

Companies are focused on strategic alliances and collaborations to enhance their market presence in addition to product innovation. Smith & Nephew plc, for example, teamed with Carestream Health in 2021 to combine its PICO negative pressure wound therapy system with Carestream’s Vue Motion medical image viewer, allowing doctors to examine wound pictures and treatment information in real time.

Overall, the pressure ulcer treatment market is likely to expand considerably in the coming years, owing to an increase in the prevalence of pressure ulcers and a growing need for better preventive and treatment alternatives.

Pressure Ulcers Treatment Market Outlook:

The worldwide pressure ulcer treatment market is predicted to rise significantly in the future years, owing to factors such as an increasing prevalence of pressure ulcers, a growing senior population, and more knowledge about the significance of pressure ulcer prevention and treatment. However, the industry is projected to experience significant hurdles, such as the high cost of innovative wound care products and qualified healthcare professionals scarcity.

The rising prevalence of pressure ulcers is one of the primary drivers of the pressure ulcer treatment industry. According to the National Pressure Ulcer Advisory Panel (NPUAP), pressure ulcers affect around 2.5 million individuals in the United States alone, with the yearly cost of treating pressure ulcers estimated to be between $9.1 and $11.6 billion. Furthermore, the aging population is predicted to contribute to market growth, since elderly people are more prone to suffering pressure ulcers due to decreased mobility.

Another factor boosting the pressure ulcer treatment market is the growing usage of sophisticated wound care products such as hydrocolloid dressings, foam dressings, and negative pressure wound therapy (NPWT) devices. These products, which outperform typical wound care solutions, are gaining appeal among healthcare experts.

However, the high cost of advanced wound care treatments is a significant market limitation, as these devices are frequently not covered by insurance and might be prohibitively expensive for some patients. Furthermore, there is a scarcity of experienced healthcare personnel educated in pressure ulcer prevention and treatment, which may limit the use of sophisticated wound care products.

According to the National Pressure Ulcer Advisory Panel (NPUAP), the prevalence of pressure ulcers in long-term care institutions in the United States ranges between 11 and 69 percent.

Overall, the pressure ulcer treatment market is likely to expand rapidly in the coming years, owing to an increase in the prevalence of pressure ulcers and an increased need for better treatment alternatives.

Segment Analysis:

The global pressure ulcer treatment market can be segmented based on product type, wound type, end-user, and region.

Based on product type, the market can be segmented into: Dressings, Topical agents, Wound care devices, Support surfaces

Dressings: Dressings are used to cover the wound and keep it from becoming infected. They also aid in the preservation of a moist environment around the wound, which aids healing. Hydrocolloid, foam, alginate, and collagen dressings are examples of dressings.

Topical agents: These are agents that are administered directly to the wound to assist in healing. Antiseptics, antibiotics, and growth hormones are examples of them.

Wound care devices: Wound care devices are used to treat and mend pressure ulcers. Negative pressure wound therapy (NPWT) systems, hyperbaric oxygen therapy (HBOT) chambers, and electrical stimulation devices are examples of these.

Support surfaces: Support surfaces are used to disperse pressure and lower the incidence of pressure ulcers. Foam mattresses, air mattresses, and gel pads are examples of these.

The dressings category is predicted to be the market leader since dressings are frequently used for pressure ulcer treatment and prevention. Dressings serve to keep the wound moist, which improves healing and minimizes the risk of infection.

Based on wound type, the market can be segmented into: Stage 1 Stage 2 Stage 3 Stage 4 Unstageable

Stage 1 pressure ulcers are the least severe and feature undamaged but red or discolored skin. The damaged region may be treated by easing pressure on it and using dressings or topical medications.

Stage 2: Pressure ulcers in this stage have a partial thickness loss of skin and may include blistering or shallow craters. Dressings, topical treatments, or wound care devices may be used in treatment.

Stage 3 pressure ulcers entail a complete loss of skin thickness and may involve damage to underlying tissue. Wound care devices, surgical debridement, or skin transplants may be used in treatment.

Stage 4: The most severe pressure ulcers entail complete thickness loss of skin and tissue and muscle and bone damage. Wound care devices, surgical debridement, and other sophisticated procedures may be used in therapy.

The stage 2 category is predicted to be the market leader, as stage 2 pressure ulcers are the most prevalent kind of pressure ulcer.

Based on end-user, the market can be segmented into: Hospitals and clinics, home care settings, Others

Hospitals and clinics: Because they have the resources and experience to treat severe cases, hospitals, and clinics are the major locations for pressure ulcer therapy.

Home care settings: Home care settings can be utilized for less severe pressure ulcers or continuous pressure ulcer management.

Others: Long-term care homes, rehabilitation centers, and other healthcare settings are included in this sector.

As pressure ulcers are often treated in healthcare facilities, the hospitals and clinics sector is likely to be the market leader.

Due to the rising usage of sophisticated wound care products such as negative pressure wound therapy (NPWT) systems and hyperbaric oxygen therapy; the wound care devices sector is predicted to be the fastest expanding section in the pressure ulcers treatment market (HBOT).

Geographical Analysis:

Based on geography the Pressure Ulcers Treatment Market has been segmented into five main regions namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.

North America: Due to the high frequency of pressure ulcers and the existence of a significant number of hospitals and healthcare institutions in the region, North America is the leading market for pressure ulcer therapy. Each year, more than 2.5 million people in the United States get pressure ulcers, according to the National Pressure Ulcer Advisory Panel (NPUAP).

Europe is the second largest market for pressure ulcer therapy, owing to an increase in the prevalence of pressure ulcers among the senior population and a greater emphasis on preventative measures. According to the European Pressure Ulcer Advisory Panel’s (EPUAP) study, the prevalence of pressure ulcers in Europe is estimated to be between 4% and 20%.

The Asia Pacific pressure ulcer treatment market is predicted to be the fastest expanding category, driven by an aging population and increased awareness of pressure ulcer prevention and management. According to the United Nations, Asia’s population of persons aged 60 and above is predicted to reach 1.3 billion by 2050, up from 650 million in 2019.